Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop

Resistance to chemotherapy, a major therapeutic challenge in the treatment of T-cell acute lymphoblastic leukemia (T-ALL), can be driven by interactions between leukemic cells and the microenvironment that promote survival of leukemic cells. The bone marrow, an important leukemia niche, has low oxyg...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Blood Adv
Prif Awduron: Fahy, Lucine, Calvo, Julien, Chabi, Sara, Renou, Laurent, Le Maout, Charly, Poglio, Sandrine, Leblanc, Thierry, Petit, Arnaud, Baruchel, André, Ballerini, Paola, Naguibneva, Irina, Haddad, Rima, Arcangeli, Marie-Laure, Mazurier, Frederic, Pflumio, Francoise, Uzan, Benjamin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Hematology 2021
Pynciau:
Lymphoid Neoplasia
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839374/
https://ncbi.nlm.nih.gov/pubmed/33496749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002832
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg